Vfend Special Investigation For Prophylaxis

Non-Interventional Post Marketing Surveillance Study To Observe The Safety And Efficacy Of Vfend® Tablet In Korea

NCT01073631 ·Status: COMPLETED

A Study to Evaluate the Appropriateness of the Voriconazole Dosing Regimen

NCT03760276 ·Status: COMPLETED ·Phase: PHASE1

Study Of The Pharmacokinetics And Safety Of Voriconazole In Children 2 To 11 Years Old Who Are At High Risk For Systemic Fungal Infection

NCT00739934 ·Status: COMPLETED ·Phase: PHASE2

Phase I Clinical Trial for Comparison of Pharmacokinetic Characteristics of Vorico Injection 200mg(Voriconazole) and Vfend® IV 200mg for Single Dose Crossover Intravenous Infusion in Healthy Volunteers

NCT02631954 ·Status: COMPLETED ·Phase: PHASE1

Open, Non Comparative Study Of Voriconazole In Slovak Patients With Very High Risk Of Developing An Invasive Fungal Infection

NCT01137292 ·Status: COMPLETED

An Open-Label Study To Assess The Pharmacokinetics, Safety And Toleration Of Vfend®; Following Multiple Dosing With Vfend

NCT00150319 ·Status: TERMINATED ·Phase: PHASE1/PHASE2

Determination of Voriconazole Levels in Saliva - Validation in Specific Subsets of Patients

NCT01418846 ·Status: COMPLETED

A Study to Investigate the Pharmacokinetics, Safety and Tolerability of Voriconazole in Children

NCT00174473 ·Status: COMPLETED ·Phase: PHASE1/PHASE2

A Pharmacokinetic And Safety Study Of Voriconazole In Healthy Male And Female Adults

NCT00855101 ·Status: COMPLETED ·Phase: PHASE1

A Clinical Study Intended To Compare Treatment With Voriconazole To Treatment With Amphotericin Followed By Fluconazole In Patients With Candidemia, A Serious Fungus Infection Of The Blood.

NCT00163111 ·Status: COMPLETED ·Phase: PHASE3

Pharmacokinetics of Two Different Formulation of Voriconazole

NCT02912156 ·Status: COMPLETED ·Phase: PHASE4

Assessment of Voriconazole Penetration Into the Brain by Fluorine-Magnetic Resonance Spectroscopy

NCT00136968 ·Status: COMPLETED ·Phase: PHASE1

A Study Of The Safety, Tolerability And Effective Of Voriconazole For The Treatment Of Serious Candida Infection And Candida Infection Of The Throat In Pediatric Patients

NCT01092832 ·Status: TERMINATED ·Phase: PHASE3

A Study To Assess The Efficacy And Safety Of Voriconazole In Chinese Patients With Serious Deep Tissue Fungal Infections

NCT00288197 ·Status: COMPLETED ·Phase: PHASE4

Voriconazole For Chronic Bronchopulmonary Aspergillosis

NCT00159822 ·Status: COMPLETED ·Phase: PHASE2/PHASE3

Effect of Inflammation on Voriconazole Concentration

NCT02074462 ·Status: COMPLETED

Study to Test the Combination of Voriconazole and Anidulafungin in Patients Who Have, or Are Thought to Have, Invasive Aspergillosis and Who Are Unable to Take a Common Antifungal Therapy (Polyene)

NCT00620074 ·Status: TERMINATED ·Phase: PHASE4

Study Will Evaluate The Safety And Efficacy Of Anidulafungin In Patients With Candidemia Or Invasive Candidiasis

NCT00496197 ·Status: COMPLETED ·Phase: PHASE4

Influence of SLCO2B1 Polymorphism on the PK of Voriconazole in CYP2C19 PM

NCT02906176 ·Status: COMPLETED ·Phase: PHASE1

Voriconazole Blood Levels and Toxicity

NCT00359541 ·Status: COMPLETED

A Study To Evaluate The Safety Of Voriconazole As Treatment Of Invasive Aspergillosis (Fungal Infection) And Other Rare Molds In Children

NCT00836875 ·Status: TERMINATED ·Phase: PHASE3

Evaluation Of The Importance Of Risk-Factor Adjustment For Assessing The Relationship Between Voriconazole Utilization And The Development Of Non-Melanoma Skin Cancer Among Lung And Heart/Lung Transplant Patients, 2002-2009g

NCT01480219 ·Status: COMPLETED

Voriconazole to Treat Fungal Infections

NCT00001940 ·Status: COMPLETED ·Phase: PHASE3

Voriconazole as Prophylaxis for Liver Transplant Recipients

NCT00177788 ·Status: COMPLETED

Efficacy and Safety of Different Doses of Venus Association in Patients With Vulvovaginal Candidiasis.

NCT05031481 ·Status: WITHDRAWN ·Phase: PHASE2